Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice.
Baroreflex
Blood pressure
GABA
Hindbrain
RAS
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
received:
17
07
2020
accepted:
10
03
2021
pubmed:
17
3
2021
medline:
17
3
2022
entrez:
16
3
2021
Statut:
ppublish
Résumé
These studies evaluate whether angiotensin type-2 receptors (AT2Rs) that are expressed on γ-aminobutyric acid (GABA) neurons in the nucleus of the solitary tract (NTS) represent a novel endogenous blood pressure-lowering mechanism. Experiments combined advanced genetic and neuroanatomical techniques, pharmacology, electrophysiology, and optogenetics in mice to define the structure and cardiovascular-related function of NTS neurons that contain AT2R. Using mice with Cre-recombinase directed to the AT2R gene, we discovered that optogenetic stimulation of AT2R-expressing neurons in the NTS increases GABA release and blood pressure. To evaluate the role of the receptor, per se, in cardiovascular regulation, we chronically delivered C21, a selective AT2R agonist, into the brains of normotensive mice and found that central AT2R activation reduces GABA-related gene expression and blunts the pressor responses induced by optogenetic excitation of NTS AT2R neurons. Next, using in situ hybridization, we found that the levels of Agtr2 mRNAs in GABAergic NTS neurons rise during experimentally induced hypertension, and we hypothesized that this increased expression may be exploited to ameliorate the disease. Consistent with this, final experiments revealed that central administration of C21 attenuates hypertension, an effect that is abolished in mice lacking AT2R in GABAergic NTS neurons. These studies unveil novel hindbrain circuits that maintain arterial blood pressure, and reveal a specific population of AT2R that can be engaged to alleviate hypertension. The implication is that these discrete receptors may serve as an access point for activating an endogenous depressor circuit.
Identifiants
pubmed: 33723600
pii: 6173399
doi: 10.1093/cvr/cvab085
pmc: PMC9020199
doi:
Substances chimiques
Imidazoles
0
Receptor, Angiotensin, Type 2
0
Sulfonamides
0
Thiophenes
0
compound 21
RC2V4W0EYC
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
883-896Subventions
Organisme : NHLBI NIH HHS
ID : R35 HL150750
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL136595
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL096830
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL125805
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL093186
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL122494
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL145028
Pays : United States
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Références
Circulation. 2019 Jul 9;140(2):138-146
pubmed: 31014072
Neuropharmacology. 2014 Jun;81:134-41
pubmed: 24508710
Natl Vital Stat Rep. 2018 Jul;67(6):1-77
pubmed: 30248017
Exp Physiol. 2014 Dec 1;99(12):1597-610
pubmed: 25239924
Endocrinology. 2016 Aug;157(8):3167-80
pubmed: 27267713
Neuroscience. 2000;99(4):613-26
pubmed: 10974425
Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H116-21
pubmed: 12388241
J Comp Neurol. 1996 Sep 23;373(3):322-39
pubmed: 8889931
Front Neurosci. 2017 Aug 15;11:461
pubmed: 28860965
Brain Res. 1987 Feb 17;403(2):279-89
pubmed: 3828822
Curr Hypertens Rep. 2018 Feb 26;20(2):11
pubmed: 29480411
Nature. 1995 Oct 26;377(6551):748-50
pubmed: 7477267
J Neurophysiol. 2008 Apr;99(4):1712-22
pubmed: 18272881
Am J Hypertens. 2015 Mar;28(3):355-61
pubmed: 25156625
Hypertension. 2010 Feb;55(2):201-6
pubmed: 20048192
Auton Neurosci. 2011 Jan 20;159(1-2):62-70
pubmed: 20837402
Clin Sci (Lond). 2015 Jul;129(1):81-92
pubmed: 25655919
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):384-93
pubmed: 15854147
Front Neurosci. 2019 Jun 05;13:589
pubmed: 31231188
Hypertension. 2014 Mar;63(3):572-9
pubmed: 24343120
Brain Res. 1982 Nov;257(3):275-325
pubmed: 6756545
JACC Basic Transl Sci. 2020 Jul 15;5(8):799-810
pubmed: 32875170
Hypertension. 2014 Oct;64(4):777-83
pubmed: 24958505
Circulation. 2016 Sep 20;134(12):847-57
pubmed: 27576780
Physiology (Bethesda). 2015 Mar;30(2):148-58
pubmed: 25729060
Integr Blood Press Control. 2013 Nov 22;6:153-61
pubmed: 24379697
Oxid Med Cell Longev. 2016;2016:3981790
pubmed: 26783414
Brain Struct Funct. 2016 Mar;221(2):891-912
pubmed: 25427952
Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H987-93
pubmed: 12456390
Hypertens Res. 2020 Apr;43(4):281-295
pubmed: 31853042
J Chem Neuroanat. 2009 May;37(3):182-95
pubmed: 19146948
Nature. 1995 Oct 26;377(6551):744-7
pubmed: 7477266
J Neurosci. 2017 Mar 29;37(13):3478-3490
pubmed: 28219987
Hypertension. 2020 Jan;75(1):6-15
pubmed: 31786978
Curr Opin Pharmacol. 2011 Apr;11(2):187-92
pubmed: 21167778
Curr Opin Pharmacol. 2015 Apr;21:115-21
pubmed: 25677800
Curr Hypertens Rep. 2017 Apr;19(4):32
pubmed: 28353076
Lancet. 2017 Dec 16;390(10113):2655-2661
pubmed: 28870716
Hypertension. 2003 Oct;42(4):732-6
pubmed: 12874097
Annu Rev Physiol. 1994;56:93-116
pubmed: 7912060